Ordered Autophagy Substrate Clearance as a Gatekeeper of Epigenetic Reset in Cyclic Partial Reprogramming
Hypothesis
During cyclic OSKM‑induced partial reprogramming, autophagy does not merely remove damaged mitochondria first; it executes a tightly ordered substrate hierarchy—mitophagy → ER‑phagy → aggrephagy → ribophagy—that gates the epigenetic reset. Disrupting the sequence, for example by delaying ER‑phagy while keeping mitophagy intact, will uncouple mitochondrial ROS reduction from chromatin remodeling and produce incomplete reprogramming despite normal autophagy flux.
Rationale
Recent work shows a transient autophagy peak early in reprogramming that depends on Sox2‑mediated mTOR suppression and is required for efficiency1. Mitophagy reduces ROS2 and continuous autophagy blocks iPSC formation, indicating a need for precise timing1. Outside reprogramming, stress‑induced muscle atrophy shifts autophagic selectivity toward ER‑phagy, with OPTN and SEC62 up‑regulated early4, proving cells can re‑prioritize cargos. Yet no study has tracked the full order of organelle clearance during cyclic OSKM pulses or linked receptor dynamics to demethylation waves that occur mainly during recovery phases3.
We propose that the hierarchy functions as a molecular checkpoint: mitochondria are cleared first to lower ROS, permitting safe ER‑stress relief; ER‑phagy then reduces unfolded protein load, allowing chromatin remodelers access; aggrephagy removes toxic aggregates that would otherwise sequester transcription factors; finally ribophagy modulates translation to match the new transcriptional program. If any step is skipped or delayed, downstream events proceed on a flawed substrate, leading to aberrant epigenetics and reduced rejuvenation.
Predictions
- In cyclic OSKM cells, mitophagy flux (measured by mt‑Keima) will peak before ER‑phagy flux (measured by SEC62‑GFP), which will precede aggrephagy (marked by p62‑positive puncta) and ribophagy (marked by RPL‑LLCP).
- Pharmacological inhibition of ER‑phagy (e.g., using sec62 siRNA) after mitophagy completion will sustain low ROS but impair H3K27ac redistribution and reduce OCT4‑SOX2‑NANOG expression despite normal LC3‑II turnover.
- Ribophagy blockade will cause lingering global protein synthesis, maintaining a somatic translational signature and preventing the downregulation of lineage‑specific markers seen in successful reprogramming.
- Restoring the ordered sequence—forcing ER‑phagy before mitophagy—will not rescue reprogramming, indicating the hierarchy is direction‑specific.
Experimental Design
- Model: Mouse embryonic fibroblasts inducible for OSKM with a 2‑day on/5‑day off cycle.
- Readouts: Live‑cell reporters for each autophagic pathway (mt‑Keima, SEC62‑GFP, GFP‑p62, RPL‑LLCP‑mCherry), ROS (CellROX), chromatin accessibility (ATAC‑seq) and transcriptome (scRNA‑seq) sampled every 6 h across cycles.
- Interventions: (a) CRISPRi of SEC62 to delay ER‑phagy, (b) Bafilomycin A1 pulse to block autophagosome‑lysosome fusion at specific windows, (c) Overexpression of RPL13A to inhibit ribophagy.
- Analysis: Compare epigenetic reset metrics (DNA methylation age, H3K9me3 loss) and reprogramming efficiency (colonies alkaline‑positive) between control and sequenced‑disruption conditions.
Potential Implications
If the ordered autophagy sequence proves essential, it shifts the focus from merely boosting autophagy flux to timing substrate specificity. This could explain why rapamycin or chronic autophagy activators fail in aging models—they may flatten the hierarchy. Therapeutic strategies that transiently enhance specific receptors (e.g., OPTN agonists) in sync with reprogramming pulses might improve epigenetic rejuvenation without triggering maladaptive self‑digestion.